[Malignant melanoma of the conjunctiva and eyelids: analysis of prognosis in 56 cases (author's transl)].
Long-term prognosis was analyzed by a retrospective study of 56 patients with malignant melanoma of the conjunctiva and the eyelids. Survival rate at 5 years was 85 p. cent, at 10 years 68 p. cent, and at 15 or 20 years 55 p. cent; neither the localization of the tumor nor the type of initial treatment had a significant influence on these rates. Local or nodal recurrences occurred in 80 p. cent of cases, and were frequent following conservative surgery; prognosis is bad after radiotherapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D003230:Conjunctival Neoplasms / Q000473:pathology / Q000628:therapy*; D005142:Eyelid Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012189:Retrospective Studies
Le pronostic des mélanomes malins de la conjonctivite et des paupières: étude statistique sur 56 patients.